Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Researchers typically start with a daily dose of 1-2 mg of GHK-Cu, administered subcutaneously, for an experiment duration of 30 days
(The beautiful blue hue indicates the copper peptide's activation!)
Compared to oral supplements, this leads to quicker and more effective results
Higher risk scores indicated a higher level of gene expression, which in turn led to higher production of GLP-1 agonists
20 The CALGB 9343 study focuses on elderly low-risk HR+ breast cancer patients, comparing the outcomes of tamoxifen plus radiotherapy versus tamoxifen alone
[1] [5] This reduces the risk of hypoglycemia compared to some other diabetes medications
